Bispecific anti-ErbB-1/anti-c-Met antibodies

Details for Australian Patent Application No. 2010233993 (hide)

Owner Roche Glycart AG

Inventors Bossenmaier, Birgit; Brinkmann, Ulrich; Klein, Christian; Niederfellner, Gerhard; Schaefer, Wolfgang; Schanzer, Juergen Michael; Sustmann, Claudio; Umana, Pablo

Agent Davies Collison Cave

Pub. Number AU-A-2010233993

PCT Pub. Number WO2010/115551

Priority 09005109.5 07.04.09 EP

Filing date 30 March 2010

Wipo publication date 14 October 2010

International Classifications

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 35/00 (2006.01) Antineoplastic agents

C07K 16/46 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - Hybrid immunoglobulins

C07K 14/71 (2006.01) Peptides having more than 20 amino acids

Event Publications

8 September 2011 PCT application entered the National Phase

  PCT publication WO2010/115551 Priority application(s): WO2010/115551

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010233994-Bispecific anti-ErbB-3/anti-c-Met antibodies

2010233988-Defoliant comprising thidiazuron and 1,2,4-triazinones